PSNL
Personalis Inc
NASDAQ: PSNL · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.86
-0.63% today
Updated 2026-11-12
Market cap
$1.71B
P/E ratio
—
P/S ratio
21.19x
EPS (TTM)
$-1.16
Dividend yield
—
52W range
$5 – $19
Volume
2.3M
Personalis Inc (PSNL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.86
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$6.23
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -2.40% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -147.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.